HomeCompareZEUS vs MRK

ZEUS vs MRK: Dividend Comparison 2026

ZEUS yields 1.34% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZEUS wins by $12.66M in total portfolio value· pulled ahead in Year 4
10 years
ZEUS
ZEUS
● Live price
1.34%
Share price
$47.86
Annual div
$0.64
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12.72M
Annual income
$11,121,408.41
Full ZEUS calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ZEUS vs MRK

📍 ZEUS pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZEUSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZEUS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZEUS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZEUS
Annual income on $10K today (after 15% tax)
$113.66/yr
After 10yr DRIP, annual income (after tax)
$9,453,197.15/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ZEUS beats the other by $9,444,868.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZEUS + MRK for your $10,000?

ZEUS: 50%MRK: 50%
100% MRK50/50100% ZEUS
Portfolio after 10yr
$6.39M
Annual income
$5,565,603.28/yr
Blended yield
87.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ZEUS
Analyst Ratings
3
Buy
3
Hold
Consensus: Buy
Price Target
$41.00
-14.3% upside vs current
Range: $41.00 — $41.00
Altman Z
3.5
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZEUS buys
0
MRK buys
0
No recent congressional trades found for ZEUS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZEUSMRK
Forward yield1.34%2.76%
Annual dividend / share$0.64$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$12.72M$56.8K
Annual income after 10y$11,121,408.41$9,798.13
Total dividends collected$12.57M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$41.00$128.54

Year-by-year: ZEUS vs MRK ($10,000, DRIP)

YearZEUS PortfolioZEUS Income/yrMRK PortfolioMRK Income/yrGap
1$10,967$267.45$11,206$366.19$239.00MRK
2$12,283$548.26$12,650$502.35$367.00MRK
3$14,291$1,147.76$14,407$694.19$116.00MRK
4← crossover$17,787$2,495.97$16,585$967.82+$1.2KZEUS
5$24,839$5,806.76$19,342$1,363.89+$5.5KZEUS
6$41,735$15,156.77$22,913$1,947.19+$18.8KZEUS
7$92,257$47,600.61$27,662$2,823.89+$64.6KZEUS
8$295,394$196,679.57$34,159$4,173.35+$261.2KZEUS
9$1,493,161$1,177,088.75$43,337$6,308.80+$1.45MZEUS
10$12,719,090$11,121,408.41$56,776$9,798.13+$12.66MZEUS

ZEUS vs MRK: Complete Analysis 2026

ZEUSStock

Olympic Steel, Inc. processes, distributes, and storage metal products in the United States and internationally. It operates in three segments: Carbon Flat Products; Specialty Metals Flat Products; and Tubular and Pipe Products. The Carbon Flat Products segment sells and distributes processed carbon and coated flat-rolled sheets, coil and plate products, and fabricated parts. The Specialty Metals Flat Products segment sells and distributes processed aluminum and stainless flat-rolled sheets and coil products, flat bar products, and fabricated parts, as well as stainless steel and aluminum plates, sheets, angles, rounds, flat bars, tubing and pipe, and prime tin mill products. The Tubular and Pipe Products segment distributes metal tubing products, pipes, bars, valves and fittings, and fabricated pressure parts. The company also provides various processing services comprising cutting-to-length, slitting, shearing, roll forming, shape correction, surface improvement, blanking, tempering, plate burning, and stamping as well as offers value-added processing of saw cutting, laser cutting, beveling, threading, and grooving services. In addition, the company provides shot blasting, grinding, edging, and polishing; bending, drilling, milling, tapping, boring, and sawing metal; machining, welding, assembly, and painting of component parts. Further, the company process metals to specified lengths, widths, shapes, and surface. It serves metal consuming industries, such as manufacturers and fabricators of transportation and material handling lift equipment, construction, mining and farm equipment, agriculture equipment, storage tanks, environmental and energy generation equipment, automobiles, food service, commercial appliances, and electrical equipment as well as military vehicles and equipment, general and plate fabricators, and metals service centers through direct sales force. Olympic Steel, Inc. was founded in 1954 and is based in Bedford Heights, Ohio.

Full ZEUS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ZEUS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZEUS vs SCHDZEUS vs JEPIZEUS vs OZEUS vs KOZEUS vs MAINZEUS vs JNJZEUS vs ABBVZEUS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.